November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreNovember 01, 2025
The simulators market size is projected to expand from USD 14.72 billion in 2026 to USD 25.53 billion by 2034,...
Read MoreNovember 01, 2025
The automated and closed cell therapy processing systems market size is calculated at $1.74 bn in 2025 is to hit $8.86 bn by 2034. The automated and closed cell therapy market sees key advancements: Cellular Origins partnered with Fresenius Kabi (Oct 2024) for robotic manufacturing; Multiply Labs collaborated with Stanford Medicine (Apr 2024) on au...
November 01, 2025
The food allergy treatment market size is calculated at $7.47 bn in 2025 is to hit $15.32 bn by 2034. In 2024, notable advancements in food allergy treatment include Mitsubishi Gas Chemical's partnership with Alerje to enhance global allergy care, the U.S. FDA's approval of Xolair for severe allergies, and Inimmune's collaboration with Intrommune t...
November 01, 2025
The organ transplant immunosuppressant drugs market size is calculated at $5.81 bn in 2025 is to hit $8.82 bn by 2034. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diabetes. Duke Children’s Hospital launched a trial on new anti-rejection medications in children. Astel...
November 01, 2025
The cholera vaccines market size is calculated at $103.99 mn in 2025 is to hit $246 mn by 2034. In early 2025, Nakonde, Zambia, launched a cholera vaccination campaign targeting 191,153 people. In October 2024, India’s ICMR and NIRBD began a pilot project to vaccinate 50,000 individuals with Euvichol-Plus. In March 2024, IVI initiated a tech ...
November 01, 2025
The enzyme replacement therapy market size is calculated at $11.34 bn in 2025 is to hit $24.71 bn by 2034. In January 2025, Denali Therapeutics received FDA Breakthrough Therapy Designation for DNL310 (tividenofusp alfa) for Hunter syndrome. In July 2024, GC Biopharma’s GC1130A got fast-track status for Sanfilippo syndrome type A. In December...
November 01, 2025
The U.S. pharmaceutical CDMO market size is calculated at $39.14 bn in 2025 is to hit $68.57 bn by 2034. The U.S. Pharmaceutical CDMO market is evolving with key developments in 2024. Recipharm partnered with Exela Pharma for sterile manufacturing, Agilent acquired Biovectra for $925M to expand its CDMO capabilities, and Thermo Fisher's biopharma r...
November 01, 2025
The cold pain therapy market size is calculated at $2.59 bn in 2025 is to hit $3.70 bn by 2034. The cold pain therapy market is evolving with key developments: Artica Systems partnered with Olympic Cryo (Nov 2024) to expand cryotherapy solutions in the U.S., CSA Medical secured $53M (Sep 2024) for its RejuvenAir system, and Aspen Medical teamed wit...
November 01, 2025
The stroke rehabilitation market size is calculated at $317.02 mn in 2025 is to hit $817.06 mn by 2034. In 2024, North America led the market, while Asia-Pacific is projected to grow fastest during the forecast period. The ischemic stroke segment dominated the stroke rehabilitation market, but hemorrhagic stroke will see notable growth. Hospitals l...
November 01, 2025
The GLP-1 receptor agonist market size is calculated at $62.86 bn in 2025 is to hit $268.37 bn by 2034. GLP-1 receptor agonists are peptide drugs that mimic the GLP-1 hormone to lower blood glucose and aid weight loss. With rising diabetes and obesity rates, the market is growing. Recent developments include Eli Lilly's Zepbound, Novo Nordisk's par...
November 01, 2025
The allergy immunotherapy market size is calculated at $2.12 bn in 2025 is to hit $4.50 bn by 2034. In 2024, Europe led the allergy immunotherapy market share of 68%, with subcutaneous immunotherapy dominating treatment types. The tablets segment held the largest market share, while the drops segment is expected to grow significantly. The allergy r...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com